• search hit 15 of 16
Back to Result List

Five year follow up of extremely low gestational age infants after timely or delayed administration of routine vaccinations

Please always quote using this URN: urn:nbn:de:bvb:20-opus-239592
  • This study is aimed at detecting the rate of untimely immunization in a large cohort of extremely low gestational age neonates (ELGANs) of the German Neonatal Network (GNN) and at addressing risk factors for delayed vaccination and associated long-term consequences. We performed an observational study of the GNN between 1st January 2010 and 31st December 2019. The immunization status for the hexavalent and pneumococcal immunization was evaluated in n = 8401 preterm infants <29 weeks of gestation. Univariate analysis and logistic/linearThis study is aimed at detecting the rate of untimely immunization in a large cohort of extremely low gestational age neonates (ELGANs) of the German Neonatal Network (GNN) and at addressing risk factors for delayed vaccination and associated long-term consequences. We performed an observational study of the GNN between 1st January 2010 and 31st December 2019. The immunization status for the hexavalent and pneumococcal immunization was evaluated in n = 8401 preterm infants <29 weeks of gestation. Univariate analysis and logistic/linear regression models were used to identify risk factors for vaccination delay and outcomes at a 5-year follow-up. In our cohort n = 824 (9.8%) ELGANs did not receive a timely first immunization with the hexavalent and pneumococcal vaccine. Risk factors for delayed vaccination were SGA status (18.1% vs. 13.5%; OR 1.3; 95% CI: 1.1–1.7), impaired growth and surrogates for complicated clinical courses (i.e., need for inotropes, necrotizing enterocolitis). At 5 years of age, timely immunized children had a lower risk of bronchitis (episodes within last year: 27.3% vs. 37.7%; OR 0.60, 95% CI: 0.42–0.86) but spirometry measures were unaffected. In conclusion, a significant proportion of ELGANs are untimely immunized, specifically those with increased vulnerability, even though they might particularly benefit from the immune-promoting effects of a timely vaccination.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Ingmar Fortmann, Marie-Theres Dammann, Alexander Humberg, Bastian Siller, Guido Stichtenoth, Geraldine Engels, Janina Marißen, Kirstin Faust, Kathrin Hanke, Sybelle Goedicke-Fritz, Christoph Derouet, Sascha Meyer, Regine Stutz, Elisabeth Kaiser, Egbert Herting, Wolfgang Göpel, Christoph Härtel, Michael Zemlin
URN:urn:nbn:de:bvb:20-opus-239592
Document Type:Journal article
Faculties:Medizinische Fakultät / Kinderklinik und Poliklinik
Language:English
Parent Title (English):Vaccines
ISSN:2076-393X
Year of Completion:2021
Volume:9
Issue:5
Article Number:493
Source:Vaccines (2021) 9:5, 493. https://doi.org/10.3390/vaccines9050493
DOI:https://doi.org/10.3390/vaccines9050493
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:immunization; long-term outcome; prematurity; trained immunity
Release Date:2022/09/05
Date of first Publication:2021/05/12
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International